Pharma Marketing Network

What makes a mobile app effective? That was the question posed by Jim Dayton (@JimDayton), Snr Dir Emerging Media at Intouch Solutions, at the iPharmaCONNECT...

My goal in attending conferences like CBI's iPharmaCONNECT, which is currently in progress in Philadelphia, is to come away with at least one new...

We all know that the number of pharmaceutical sales representatives have declined significantly since the high point in 2007 when approximately 105,000 members of...

I don't know if Pinterest is the next Facebook or not, but if it is, Pharma marketers are likely to stay away from it...

It may have been Einstein who defined insanity as doing the same thing over and over again and expecting different results. When I analyze...

Janssen Pharmaceuticals has announced it will shut down its Psoriasis 360 Facebook page, which was first launched in October, 2010. At the time, I...

The drug industry is laying off people left (research) and right (marketing and sales). Market research (MR) -- definitely a left brain...

Coupons for drug co-payments are illegal and drive up long-term health-care costs for all, a consumer group and four trade-union health-insurance plans said in announcing lawsuits against eight pharmaceutical companies. The lawsuits claim that although coupons reduce the consumer's out-of-pocket cost, the health insurer still pays the previously negotiated price to the drug company. With no savings from generics, health plans will need to charge patients more to keep up with rising costs, the lawsuits say.

Although many pharmaceutical companies actively use Twitter and other social media tools to push out positive news about their companies and products, very few use these tools for systematic support of patients who depend upon their drugs, which may be short supply.

This article reviews two recently published and important guidances from the FDA that concern the dissemination of drug information to consumers.